methyllycaconitine has been researched along with amyloid beta-peptides in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Freir, DB; Herron, CE | 1 |
Abdallah, DM; Ahmed, KA; El-Abhar, HS; El-Brairy, AI; Mohamed, RA | 1 |
2 other study(ies) available for methyllycaconitine and amyloid beta-peptides
Article | Year |
---|---|
Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.
Topics: Aconitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Electrophysiology; Hippocampus; Injections, Intraventricular; Long-Term Potentiation; Male; Neuronal Plasticity; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Peptide Fragments; Rats; Rats, Wistar; Receptors, Nicotinic | 2003 |
Palonosetron/Methyllycaconitine Deactivate Hippocampal Microglia 1, Inflammasome Assembly and Pyroptosis to Enhance Cognition in a Novel Model of Neuroinflammation.
Topics: Aconitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; CARD Signaling Adaptor Proteins; Cognition; Diet, Western; Disease Models, Animal; Hippocampus; Humans; Inflammasomes; Inflammation; Insulin Resistance; Interleukin-18; Lipopolysaccharides; Microglia; Palonosetron; Peptide Fragments; Pyroptosis; Rats; Receptors, Serotonin, 5-HT3; Risk Factors; Spatial Memory | 2021 |